





























Loading banners
Loading banners...


NEWS EXPRESS is Nigeria’s leading online newspaper. Published by Africa’s international award-winning journalist, Mr. Isaac Umunna, NEWS EXPRESS is Nigeria’s first truly professional online daily newspaper. It is published from Lagos, Nigeria’s economic and media hub, and has a provision for occasional special print editions. Thanks to our vast network of sources and dedicated team of professional journalists and contributors spread across Nigeria and overseas, NEWS EXPRESS has become synonymous with newsbreaks and exclusive stories from around the world.

WHO Cancer Medicine Advisory Group, Prof Fola Tayo
The World Health Organisation (WHO) has appointed a Nigerian, Prof. Fola Tayo, to serve on its Cancer Medicine Advisory Group for the availability and affordability of cancer medicines.
Tayo, who is the Pro-Chancellor and Chairman, Governing Council of Caleb University, Imota, Lagos, is among the 14 eminent people appointed across the globe to serve on the group.
Mr Elvis Otobo, the Head, Media and Public Relations Officer, Caleb University, said in a statement that the advisory group was made up of core professionals.
Otobo said that Tayo was the only person selected from West Africa.
He added that other members were from Australia, Canada, South Africa, Egypt, South Korea, Malaysia, Suriname, Malawi, Thailand, UK, Austria, Jordan and India.
The News Agency of Nigeria (NAN) reports that Fola has also been appointed to serve as the Protem Chairman of the Committee of Pro-Chancellors of Private Universities in Nigeria.
Until his appointment, he has been a very active member of the committee and made many useful contributions to the growth and development of the body in particular, and Nigeria Universities in general.
WHO’s Advisory Group is set up to define the problems relating to availability and accessibility of cancer medicines and seek expert’s advice on the scope of the report, analytical feasibility and case studies.
It is also to seek expert advice on the benefits and consequences of various pricing approaches for cancer medicines, options for improving availability and affordability of cancer medicines.
The group will brainstorm on three key projects for three days when they meet in Switzerland according to an Agenda Review released by the WHO.
These include project inception, problem definition and scope of reports; Pricing and impacts of pricing approaches and Options to improve availability, affordability and transparency of cancer medicines.
The group will be meeting in Geneva, Switzerland for its deliberations. (NAN)